Wintech Nano
688757
CHANGFU CO.,LTD
871396
DIER CHEMICAL
831304
CHENGUANG MEDICAL
430300
TLC
873576
CN Stock MarketDetailed Quotes
300966 Hubei Goto Biopharm
- 16.40
- +0.14+0.86%
Market Closed Mar 25 15:00 CST
1.89BMarket Cap-135.54P/E (TTM)
16.58High15.93Low30.38KlotVolume16.40Open16.26Pre Close49.27MTurnover3.96%Turnover Ratio82.00P/E (Static)115.28MShares23.7852wk High2.25P/B1.26BFloat Cap13.4352wk Low19.51Limit Up76.66MShs Float79.83Historical High13.01Limit Down4.00%Amplitude12.01Historical Low0.02Dividend TTM16.22Avg Price16.23KlotAsk0.10%Div YieldTTM100Lot Size13.06KlotBid
Hubei Goto Biopharm News
Kyodo Pharmaceutical: Announcement on not revising the Kyodo debt-for-equity conversion price downward
Kyodo Pharmaceutical: An indicative announcement on Kyodo Bonds expected to trigger downward revision conditions for the share conversion price
Kyodo Pharmaceutical: Announcement on the company\'s share repurchase plan and the letter of commitment to obtain a special loan to repurchase shares from financial institutions
Kyodo Pharmaceutical: Dongfang Jincheng International Credit Evaluation Co., Ltd.\'s notice on the 2024 performance pre-loss of Hubei Kyodo Pharmaceutical Co., Ltd.
Kyodo Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the fourth quarter of 2024
Kyodo Pharmaceutical: Announcement on the 2024 Interest Payment of Mutual Convertible Bonds
Kyodo Pharmaceutical: Announcement on the Election of Staff Representative Supervisors for the 3rd Board of Supervisors
Kyodo Pharmaceutical: Announcement on the completion of the election of the Board of Directors and the Board of Supervisors and the appointment of senior management
Kyodo Pharmaceutical: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Kyodo Pharmaceutical: Legal Opinion of Beijing Zhonglun (Wuhan) Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Hubei Kyodo Pharmaceutical Co., Ltd.
Kyodo Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2024
Kyodo Pharmaceutical: Announcement on the election of the board of directors for a new term
Kyodo Pharmaceutical: Announcement on the election of the Supervisory Board for a new term
Kyodo Pharmaceutical: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024
Kyodo Pharmaceutical: Dongfang Jincheng International Credit Evaluation Co., Ltd.\'s notice on Hubei Kyodo Pharmaceutical Co., Ltd.\'s 2024 semi-annual performance loss
Kyodo Pharmaceutical: Announcement on changing the sponsor representative for continuous supervision
Kyodo Pharmaceutical: 2024 Semi-Annual Financial Report
Kyodo Pharmaceutical: Summary table on the use of non-operating capital and other related capital transactions for the first half year of 2024
Hubei Goto Biopharm: Legal opinion from Beijing Zhonglun (Wuhan) Law Firm regarding the 2024 second extraordinary general meeting of shareholders of Hubei Jointown Pharmaceutical Co., Ltd.
Hubei Goto Biopharm: Announcement of resolution of the Second Extraordinary Shareholders' Meeting in 2024.
